JanOne Competitors and Similar CompaniesClear all
JanOne's competitors and similar companies include Assertio, Alembic Pharmaceuticals and UCB.
 JanOne JanOne (formerly known as ARCA) is a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. |  Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2019 | Founding Date 1995 | Founding Date 2010 | Founding Date 1928 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Las Vegas, US HQ | Locations Lake Forest, US HQ | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 1616% decrease | Employees 3058% increase | Employees 14,858 | Employees 9,052 |
Valuation ($) | Valuation ($) 27.1 m | Valuation ($) 104.9 m | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $24.8m (FY, 2025) | Revenue (est.) $118.7m (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $14.7m (FY, 2025) | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $10.2m (FY, 2025) | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($344.5m) (FY, 2025) | Net income ($30.4m) (FY, 2025) | Net income ₹6.7b (FY, 2026) | Net income €1.6b (FY, 2025) |
Operating ⚠ | ||||
Products | Products N/A | Products 8 (FY, 2020) | Products 145 (FY, 2024) | Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 2m | Total funding raised $ 42.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Assertio
HQ
Lake Forest, US
Employees
30
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company